Compumedics Property, Plant & Equipment
The Property, Plant & Equipment (PP&E) of Compumedics (CMP.AX) as of Oct 8, 2026 is 1.78 M AUD. In the previous year, Property, Plant & Equipment (PP&E) was 2.95 M AUD — a change of -39.62% (lower).
Get this data via API
Financial Data API
Property, Plant & Equipment
1.78 MAUD
YoY
-39.62%
Last updated:
The Compumedics Property, Plant & Equipment history
3 Years
10 Years
25 Years
Max
| YEAR | Property, Plant & Equipment | YoY |
|---|---|---|
| 1.78 MAUD | -39.62% | |
| 2.95 MAUD | -18.38% | |
| 3.62 MAUD | +198.27% | |
| 1.21 MAUD | -29.11% | |
| 1.71 MAUD | -44.50% | |
| 3.08 MAUD | +86.62% | |
| 1.65 MAUD | +148.05% | |
| 666,000.00AUD | -7.24% | |
| 718,000.00AUD | -13.70% | |
| 832,000.00AUD | +4.39% | |
| 797,000.00AUD | +18.60% | |
| 672,000.00AUD | — |
Compumedics Stock analysis
Frequently Asked Questions about Compumedics stock
Property, Plant & Equipment (PP&E) of Compumedics is 1.78 M AUD in 2025.
Property, Plant & Equipment (PP&E) of Compumedics changed from 2.95 M AUD to 1.78 M AUD, representing a -39.62% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Property, Plant & Equipment (PP&E) Compumedics since 2006 – with annual values, charts, and detailed analysis.
PP&E represents the physical assets used in operations, such as buildings, machinery, and equipment. It is the backbone of manufacturing and service delivery.
Property, Plant & Equipment (PP&E)'s AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Property, Plant & Equipment (PP&E)'s Compumedics historically and in real time.
Balance Sheet — Compumedics
All Key Metrics — Compumedics
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth